企業を読み込み中
Keep exploring
The themes Agilent Technologies is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Diagnostics and Research
Graded A or B and worth $2B or more: A first, then the largest.
TMOThermo Fisher Scientific Inc.$265.9BA+
IDXXIdexx Laboratories Inc.$55.4BA+
IQVIQVIA Holdings Inc.$45.2BA
ILMNIllumina, Inc.$32.2BA+
LHLabcorp Holdings Inc.$30.2BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
BIIBBiogen Inc.2026年10月28日BAGraded B, now A
どうやって稼いでいるか
- Agilent CrossLab: laboratory supplies, equipment maintenance and repair, software, and automation42%
- Life Sciences and Diagnostics Markets: instruments, clinical testing products, research supplies, and contract manufacturing for drug companies39%
- Applied Markets: instruments and software for testing chemicals, food, the environment and advanced materials19%
売上構成比はnine months ended July 31, 2026の推計であり、提出された報告書の数字ではありません。
競合
- TMOThermo Fisher ScientificA
- 規模
- $265.9B
- 利益率
- 14.9%
- DHRDanaherB
- 規模
- $165.5B
- 利益率
- 16.9%
- 7701Shimadzu Corporation
- WATWaters CorporationD
- 規模
- $46.3B
- 利益率
- 1.8%
- BRKRBrukerB
- 規模
- $9.5B
- 利益率
- -3.5%
- RHHBYRoche Ventana Medical Systems
何を売っているか6
Infinity III liquid chromatography systems
Instruments that separate the substances in a liquid sample so a laboratory can identify and measure them.
8890B and 8860B gas chromatographs
Instruments that separate and measure substances that can be turned into gas, including chemicals in fuels and contaminants in food.
9500 triple-quadrupole inductively coupled plasma mass spectrometer
An instrument that measures very small amounts of metals and other elements, including in samples used in semiconductor manufacturing.
さらに3件を表示
Altura liquid chromatography columns
Replaceable tubes that separate substances inside a chromatography system, including in testing of protein-based and nucleic-acid medicines.
Dako Omnis pathology systems
Automated instruments and related supplies used by clinical laboratories to stain and examine tissue samples for cancer diagnosis.
Oligonucleotide contract manufacturing
Manufacturing of short DNA- or RNA-like drug ingredients for pharmaceutical customers, from development through commercial production.
誰が買っているか6
- Pharmaceutical and biotechnology companies buy research instruments, testing supplies, diagnostic development services and contract manufacturing, mainly through Agilent’s direct sales teams.
- Hospitals, medical centers and reference laboratories buy pathology instruments, reagents and other products for tissue-based cancer testing.
- Clinical and molecular diagnostic laboratories buy instruments and reagents for patient testing, including genetic testing.
さらに3件を表示
- Universities, government institutes and other research organizations buy laboratory instruments, supplies and services through direct sales, distributors and resellers.
- Food, environmental and commercial testing laboratories buy instruments and supplies to test food, water, soil and other samples; public agencies also buy for monitoring and forensic work.
- Chemical, advanced-materials and semiconductor manufacturers buy instruments and services to check materials, product quality and manufacturing processes.
何に支えられ、何に崩されうるか
事業が頼っているもの
- 1Demand for some instruments depends on customers’ capital budgets, research spending and government funding.
- 2Some custom-designed parts are not readily available from alternative suppliers, and Agilent also uses outside companies for parts of manufacturing, warehousing and delivery.
- 3Sales and operations depend on meeting regulatory requirements for clinical and diagnostic products and on being able to ship products and source components across borders.
うまくいかなくなる可能性
- 1If pharmaceutical, academic, government or industrial customers reduce investment or research spending, demand for Agilent’s instruments and related products may fall.
- 2Failure to meet changing requirements for regulated diagnostic products can lead to product recalls, limits on sales or manufacturing, penalties, or loss of required approvals.
- 3Shortages of specialized parts, disruptions at outside manufacturers or delivery providers, or trade restrictions and tariffs can raise costs and delay products reaching customers.
Agilent Technologies, Inc.について
Agilent makes instruments that help laboratories identify and measure the chemicals, cells and other materials in samples. It also sells the supplies used with those instruments, maintains lab equipment, and provides software for collecting and managing test results. For drug companies, Agilent also makes ingredients used in some medicines and manufactures certain drug materials under contract.
- 本社
- Santa Clara, California
- 設立
- 1999
- 従業員数
- 18,200 (July 31, 2026, high)
- 上場市場
- NYSE
- 決算期
- October 31
Agilent Technologies, Inc. 自身が米国証券取引委員会（SEC）に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。